Thursday, April 11, 2024 6:46:48 PM
All the while diluting with 3 billion new shares?
And all of those "fresh starts" turned out to be just BS?
I'm not seeing why anyone should regard this company's new biotech merger is anything more than the next BS pump in a long line of BS pumps. As I said before, I actually expect a tweet in a few weeks about a huge AI deal.
Maybe I'm wrong, but that 3 billion share increase in the past year looks REALLY ugly on the financial statement when you realize that 3 billion new shares only reduced their debt from 34 million to 33 million.
How much of this hype is P&D artists like shartmaster buying a dead ticker at .0001 and trying to convince their "followers" into buying their stock at .0002?
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM